Publications by Hege Kersten
30 publications found
Original articles
Risk factors for SARS-CoV-2 infection: a test-negative case-control study with additional population controls in Norway
BMJ Open, 14 (1), e073766
DOI 10.1136/bmjopen-2023-073766, PubMed 38191258
SARS-CoV-2 antibody persistence after five and twelve months: A cohort study from South-Eastern Norway
PLoS One, 17 (8), e0264667
DOI 10.1371/journal.pone.0264667, PubMed 35947589
The influence of socioeconomic factors on access to disease modifying treatment in a Norwegian multiple sclerosis cohort
Mult Scler Relat Disord, 61, 103759
DOI 10.1016/j.msard.2022.103759, PubMed 35358792
The association between geriatric treatment and 30-day readmission risk among medical inpatients aged ≥75 years with multimorbidity
PLoS One, 17 (1), e0262340
DOI 10.1371/journal.pone.0262340, PubMed 34995327
Maternal education has significant influence on progression in multiple sclerosis
Mult Scler Relat Disord, 53, 103052
DOI 10.1016/j.msard.2021.103052, PubMed 34111658
Association between psychotropic drug use and handgrip strength in older hospitalized patients
Eur Geriatr Med, 12 (6), 1213-1220
DOI 10.1007/s41999-021-00511-6, PubMed 34033072
Fear of Recurrence in Prostate Cancer Patients: A Cross-sectional Study After Radical Prostatectomy or Active Surveillance
Eur Urol Open Sci, 25, 44-51
DOI 10.1016/j.euros.2021.01.002, PubMed 34337502
Prevalence of multiple sclerosis in rural and urban districts in Telemark county, Norway
Mult Scler Relat Disord, 45, 102352
DOI 10.1016/j.msard.2020.102352, PubMed 32707528
Prescribed Doses of CYP2D6-Metabolized Drugs and Hemodynamic Responses in Relation to CYP2D6 Genotype Among Older Patients Exposed to Polypharmacy
Drugs Aging, 37 (6), 425-433
DOI 10.1007/s40266-020-00763-0, PubMed 32346827
Work status and work ability after radical prostatectomy or active surveillance for prostate cancer
Scand J Urol, 54 (3), 194-200
DOI 10.1080/21681805.2020.1750473, PubMed 32285740
Quality of life of family carers of persons with young-onset dementia: A Nordic two-year observational multicenter study
PLoS One, 14 (7), e0219859
DOI 10.1371/journal.pone.0219859, PubMed 31323066
Quality of life of family carers of persons with young-onset compared to late-onset dementia
Aging Ment Health, 24 (9), 1394-1401
DOI 10.1080/13607863.2019.1617245, PubMed 31106576
Can screening tools for potentially inappropriate prescriptions in older adults prevent serious adverse drug events?
Eur J Clin Pharmacol, 75 (5), 627-637
DOI 10.1007/s00228-019-02624-1, PubMed 30662995
Quality of Life in People with Young-Onset Dementia: A Nordic Two-Year Observational Multicenter Study
J Alzheimers Dis, 67 (1), 197-210
DOI 10.3233/JAD-180479, PubMed 30530973
Quality of Life in People with Young-Onset Dementia: A Nordic Two-Year Observational Multicenter Study
J Alzheimers Dis, 71 (4), 1381
DOI 10.3233/JAD-199007, PubMed 31524177
Quality of Life in People with Young-Onset Alzheimer's Dementia and Frontotemporal Dementia
Dement Geriatr Cogn Disord, 45 (1-2), 91-104
DOI 10.1159/000487263, PubMed 29694972
Progression of Alzheimer's Disease: A Longitudinal Study in Norwegian Memory Clinics
J Alzheimers Dis, 61 (3), 1221-1232
DOI 10.3233/JAD-170436, PubMed 29254085
Trajectories of depressive symptoms and their relationship to the progression of dementia
J Affect Disord, 222, 146-152
DOI 10.1016/j.jad.2017.07.008, PubMed 28704802
Cooperation between geriatricians and general practitioners for improved pharmacotherapy in home-dwelling elderly people receiving polypharmacy - the COOP Study: study protocol for a cluster randomised controlled trial
Trials, 18 (1), 158
DOI 10.1186/s13063-017-1900-0, PubMed 28372591
Determinants of quality of life in young onset dementia - results from a European multicenter assessment
Aging Ment Health, 21 (1), 24-30
DOI 10.1080/13607863.2016.1232369, PubMed 27676211
Clinical impact of potentially inappropriate medications during hospitalization of acutely ill older patients with multimorbidity
Scand J Prim Health Care, 33 (4), 243-51
DOI 10.3109/02813432.2015.1084766, PubMed 26553225
Brief Tests such as the Clock Drawing Test or Cognistat Can Be Useful Predictors of Conversion from MCI to Dementia in the Clinical Assessment of Outpatients
Dement Geriatr Cogn Dis Extra, 4 (2), 263-70
DOI 10.1159/000363734, PubMed 25177335
Association between inherited CYP2D6/2C19 phenotypes and anticholinergic measures in elderly patients using anticholinergic drugs
Ther Drug Monit, 36 (1), 125-30
DOI 10.1097/FTD.0b013e31829da990, PubMed 24089073
Higher anticholinergic drug scale (ADS) scores are associated with peripheral but not cognitive markers of cholinergic blockade. Cross sectional data from 21 Norwegian nursing homes
Br J Clin Pharmacol, 75 (3), 842-9
DOI 10.1111/j.1365-2125.2012.04411.x, PubMed 22924454
Cognitive effects of reducing anticholinergic drug burden in a frail elderly population: a randomized controlled trial
J Gerontol A Biol Sci Med Sci, 68 (3), 271-8
DOI 10.1093/gerona/gls176, PubMed 22982689
Evaluation of brain anticholinergic activities of urinary spasmolytic drugs using a high-throughput radio receptor bioassay
J Am Geriatr Soc, 59 (3), 501-5
DOI 10.1111/j.1532-5415.2010.03307.x, PubMed 21391941
[Pharmacotherapy in nursing homes]
Tidsskr Nor Laegeforen, 129 (17), 1732-5
DOI 10.4045/tidsskr.09.34953, PubMed 19756052
Review articles
Effect of Clinical Geriatric Assessments and Collaborative Medication Reviews by Geriatrician and Family Physician for Improving Health-Related Quality of Life in Home-Dwelling Older Patients Receiving Polypharmacy: A Cluster Randomized Clinical Trial
JAMA Intern Med, 180 (2), 181-189
DOI 10.1001/jamainternmed.2019.5096, PubMed 31617562
Anticholinergic drug burden in older people's brain - how well is it measured?
Basic Clin Pharmacol Toxicol, 114 (2), 151-9
DOI 10.1111/bcpt.12140, PubMed 24112192
Theses
Betydningen av G-protein-aktiverte signalsystemer for natriumfluoridindusert apoptose i alveolære makrofager isolert fra rotte
H. Kersten, Oslo, 57 bl.
BIBSYS 991738780